Mohammed, R., Nafea, O. (2022). Is It Reasonable to Screen for Undiagnosed Diabetes and Prediabetes in Asymptomatic Individuals? A Sample from Baghdad. Alustath, 21(1), 15-21. doi: 10.52573/ipmj.2021.174066
Raed Salih Mohammed; Omar Farooq Nafea. "Is It Reasonable to Screen for Undiagnosed Diabetes and Prediabetes in Asymptomatic Individuals? A Sample from Baghdad". Alustath, 21, 1, 2022, 15-21. doi: 10.52573/ipmj.2021.174066
Mohammed, R., Nafea, O. (2022). 'Is It Reasonable to Screen for Undiagnosed Diabetes and Prediabetes in Asymptomatic Individuals? A Sample from Baghdad', Alustath, 21(1), pp. 15-21. doi: 10.52573/ipmj.2021.174066
Mohammed, R., Nafea, O. Is It Reasonable to Screen for Undiagnosed Diabetes and Prediabetes in Asymptomatic Individuals? A Sample from Baghdad. Alustath, 2022; 21(1): 15-21. doi: 10.52573/ipmj.2021.174066

Is It Reasonable to Screen for Undiagnosed Diabetes and Prediabetes in Asymptomatic Individuals? A Sample from Baghdad

Iraqi Postgraduate Medical Journal
Article 3, Volume 21, Issue 1, January 2022, Pages 15-21    PDF (282.6 K)
Document Type: Research Paper
DOI: 10.52573/ipmj.2021.174066
Authors
Raed Salih Mohammed1; Omar Farooq Nafea2
1Baghdad Teaching Hospital, Medical City, Baghdad, Iraq.
2College of Medicine, Baghdad University, Baghdad, Iraq.
Abstract
BACKGROUND:
Diabetes Mellitus is a complex chronic illness that has increased significantly around the world and is expected to affect 628 million in 2045. Undiagnosed type 2 diabetes may affect 24% - 62% of              the people with diabetes; while the prevalence of prediabetes is estimated to be 470 million cases              by 2030.
AIM OF STUDY:
To find the percentage of undiagnosed diabetes and prediabetes in a slice of people aged ≥ 45years, and relate it with age, gender, central obesity, hypertension, and family history of diabetes.
METHODS:
A cross sectional study that included 712 healthy individuals living in Baghdad who accepted to take part in this study and fulfilling the inclusion and exclusion criteria.
RESULTS:
From total 712 healthy participants, 373 (52.4%) screened negative for diabetes, 178 (25.0%) screened positive for diabetes and 161 (22.6%) had impaired fasting glucose. There was significant relation with central obesity, family history for diabetes and hypertension.
CONCLUSION:
It was concluded thatscreening for type 2 diabetes and prediabetes is reasonable, both conditions are common in people living in Baghdad and should be considered especially in people aged ≥45 years and those who are obese, have hypertension, and have a positive family history for diabetes.
 
Keywords
diabetes; prediabetes; Screening
References
  1. Alvin C, Harrison text book of Medicine 19th edition, Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology, chapter 417.
  2. Federation ID. IDF diabetes atlas 8th edition. International Diabetes Federation. 2017:905-11.
  3. Ginter E, Simko V. Type 2 diabetes mellitus, pandemic in 21st century. Diabetes. 2013:42-50.
  4. Guariguata L, Whiting D, Weil C, Unwin N. The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults. Diabetes research and clinical practice. 2011;94:322-32.
  5. Boutayeb A, Lamlili ME, Boutayeb W, Maamri A, Ziyyat A, Ramdani N. The rise of diabetes prevalence in the Arab region.
  6. Fong DS, Aiello L, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL, Klein R. Retinopathy in diabetes. Diabetes care. 2004;27:s84-7.
  7. Gross JL, De Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes care. 2005;28:164-76.
  8. Pirart J. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes care. 1978;1:168-88.
  9. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes care. 2005;28:956-62.
10. Pratley RE. The early treatment of type 2 diabetes. The American journal of medicine. 2013 ;126:S2-9.

11. World Health Organization. Global NCD target: halt the rise in diabetes. World Health Organization; 2016.

12. Bener A, Zirie M, Janahi IM, Al-Hamaq AO, Musallam M, Wareham NJ. Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes research and clinical practice. 2009;84:99-106.

13. Fisher-Hoch SP, Vatcheva KP, Laing ST, Hossain MM, Rahbar MH, Hanis CL, Brown III HS, Rentfro AR, Reininger BM, McCormick JB. Peer reviewed: missed opportunities for diagnosis and treatment of diabetes, hypertension, and hypercholesterolemia in a Mexican American population, Cameron county Hispanic cohort, 2003–2008. Preventing Chronic Disease. 2012;9..

14. Care D. Medical Care in Diabetes 2018. Diabet Care. 2018;41:S105-18.

15. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program–Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes care. 2007;30:8-13.

16. Pippitt K, Li M, Gurgle HE. Diabetes mellitus: screening and diagnosis. American family physician. 2016;93:103-9.

17. Molarius A, Seidell JC. Selection of anthropometric indicators for classification of abdominal fatness—a critical review. International journal of obesity. 1998;22:719-27.

18. Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, Badgandi M, Iyengar SS, Viswanathan V, Sivakadaksham N, Chattopadhyaya PS. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India—results from the Screening India's Twin Epidemic (SITE) study. Diabetes technology & therapeutics. 2012;14:8-15.

19. Nicol F, Robertson C. Macleod's clinical examination. Churchill Livingstone/Elsevier,; 2013.

20. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes research and clinical practice. 2014;103:150-60.

21. Mansour AA, Al-Maliky AA, Kasem B, Jabar A, Mosbeh KA. Prevalence of diagnosed and undiagnosed diabetes mellitus in adults aged 19 years and older in Basrah, Iraq. Diabetes, metabolic syndrome and obesity: targets and therapy. 2014;7:139.

22. Liu W, Hua L, Liu WF, Song HL, Dai XW, Yang JK. The prevalence of glucose metabolism disturbances in Chinese Muslims and possible risk factors: a study from northwest China. Arquivos Brasileiros de Endocrinologia & Metabologia. 2014;58:715-23.

23. Aekplakorn W, Tantayotai V, Numsangkul S, Sripho W, Tatsato N, Burapasiriwat T, Pipatsart R, Sansom P, Luckanajantachote P, Chawarokorn P, Thanonghan A. Detecting prediabetes and diabetes: agreement between fasting plasma glucose and oral glucose tolerance test in Thai adults. Journal of diabetes research. 2015;2015.

24. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE. Diabetes in older adults. Diabetes care. 2012 ;35:2650-64.

25. Patel SA, Ali MK, Alam D, Yan LL, Levitt NS, Bernabe-Ortiz A, Checkley W, Wu Y, Irazola V, Gutierrez L, Rubinstein A. Obesity and its relation with diabetes and hypertension: a cross-sectional study across 4 geographical regions. Global heart. 2016;11:71-9.

26. Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, Badgandi M, Iyengar SS, Viswanathan V, Sivakadaksham N, Chattopadhyaya PS. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India—results from the Screening India's Twin Epidemic (SITE) study. Diabetes technology & therapeutics. 2012;14:8-15.

Statistics
Article View: 138
PDF Download: 110


Journal Management System. Powered by ejournalplus.com